圣达生物2025年净利润预计增长69.93%~120.90%

Core Viewpoint - Shengda Bio (603079) announced on January 22 that it expects a significant increase in net profit for 2025, projecting a range of 50 million to 65 million yuan, representing a year-on-year growth of 69.93% to 120.90% [1] Financial Performance - The company anticipates net profit to be between 50 million yuan and 65 million yuan for the year 2025 [1] - This projection indicates a substantial year-on-year increase in net profit, with growth rates estimated between 69.93% and 120.90% [1]